Immunohistochemical profiles of IDH1, MGMT and P53: Practical significance for prognostication of patients with diffuse gliomas

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1789|35|4|324-335

ISSN： 0919-6544

Source： Neuropathology (Electronic), Vol.35, Iss.4, 2015-08, pp. : 324-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association of p53 tumor suppressor gene with paraclinical and clinical modalities of gliomas patients in Malaysia

By Yusoff A. A.   Abdullah J.   Abdullah M. R.   Mohd Ariff A. R.   Isa M. N.  

Acta Neurochirurgica, Vol. 146, Iss. 6, 2004-06 ,pp. : 595-601

Springer Publishing Company

Access to resources Recommend Favorite

IDH2 mutation in gliomas including novel mutation

By  

Neuropathology (Electronic), Vol. 35, Iss. 3, 2015-06 ,pp. : 236-244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma

By Korshunov Andrey  

Acta Neuropathologica, Vol. 118, Iss. 3, 2009-09 ,pp. : 401-405

Springer Publishing Company

Access to resources Recommend Favorite

Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results

By Li Shouwei   Jiang Tao   Li Guilin   Wang Zhongcheng  

Neurological Research, Vol. 30, Iss. 6, 2008-07 ,pp. : 567-570

Maney Publishing

Access to resources Recommend Favorite

Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy

By Li Shouwei   Zhang Wei   Chen Baoshi   Jiang Tao   Wang Zhongcheng  

Neurological Research, Vol. 32, Iss. 7, 2010-09 ,pp. : 690-694

Maney Publishing

Access to resources Recommend Favorite